Kenji Okuda

7.6k total citations · 1 hit paper
204 papers, 6.1k citations indexed

About

Kenji Okuda is a scholar working on Immunology, Molecular Biology and Virology. According to data from OpenAlex, Kenji Okuda has authored 204 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Immunology, 77 papers in Molecular Biology and 45 papers in Virology. Recurrent topics in Kenji Okuda's work include Immunotherapy and Immune Responses (43 papers), HIV Research and Treatment (42 papers) and Immune Cell Function and Interaction (35 papers). Kenji Okuda is often cited by papers focused on Immunotherapy and Immune Responses (43 papers), HIV Research and Treatment (42 papers) and Immune Cell Function and Interaction (35 papers). Kenji Okuda collaborates with scholars based in Japan, United States and Sweden. Kenji Okuda's co-authors include Ke-Qin Xin, Kenji Hamajima, Masaru Shimada, Takehiro Ura, Susumu Kawamoto, Fumihiko Takeshita, Jun Fukushima, Norihisa Ishii, Nao Jounai and Dennis M. Klinman and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Kenji Okuda

201 papers receiving 5.9k citations

Hit Papers

Developments in Viral Vector-Based Vaccines 2014 2026 2018 2022 2014 100 200 300

Peers

Kenji Okuda
Manmohan Singh United States
Alana Althage United States
Ralf Wagner Germany
Ronald C. Kennedy United States
Gary R. Klimpel United States
J. Lindsay Whitton United States
Kenji Okuda
Citations per year, relative to Kenji Okuda Kenji Okuda (= 1×) peers Hajime Tsujimoto

Countries citing papers authored by Kenji Okuda

Since Specialization
Citations

This map shows the geographic impact of Kenji Okuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Okuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Okuda more than expected).

Fields of papers citing papers by Kenji Okuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Okuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Okuda. The network helps show where Kenji Okuda may publish in the future.

Co-authorship network of co-authors of Kenji Okuda

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Okuda. A scholar is included among the top collaborators of Kenji Okuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Okuda. Kenji Okuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakajima, Sadahiko & Kenji Okuda. (2024). Degraded contingency effect on running-based flavor aversion in rats: Testing the associative cue-competition account with flavors of minimal similarity. Learning and Motivation. 88. 102061–102061. 1 indexed citations
2.
Saha, Sukumar, et al.. (2024). Clinical Application of Adenovirus (AdV): A Comprehensive Review. Viruses. 16(7). 1094–1094. 11 indexed citations
3.
Aoki, Akira, Yoko Mori, Miyabi Ito, et al.. (2023). A modified high-resolution melting-based assay (HRM) to identify the SARS-CoV-2 N501Y variant. Journal of Virological Methods. 314. 114678–114678. 3 indexed citations
4.
Ito, Saori, Takehiro Ura, Jun Fukushima, et al.. (2021). Prophylactic and therapeutic vaccine against Pseudomonas aeruginosa keratitis using bacterial membrane vesicles. Vaccine. 39(23). 3152–3160. 13 indexed citations
5.
Okuda, Kenji, et al.. (2014). DroidTrack: Tracking and Visualizing Information Diffusion for Preventing Information Leakage on Android.. 4. 55–69. 14 indexed citations
6.
Akatsu, Hiroyasu, Noriyuki Iwabuchi, Jin‐zhong Xiao, et al.. (2012). Clinical Effects of Probiotic Bifidobacterium longum BB536 on Immune Function and Intestinal Microbiota in Elderly Patients Receiving Enteral Tube Feeding. Journal of Parenteral and Enteral Nutrition. 37(5). 631–640. 67 indexed citations
7.
Kobiyama, Kouji, Fumihiko Takeshita, Nao Jounai, et al.. (2009). Extrachromosomal Histone H2B Mediates Innate Antiviral Immune Responses Induced by Intracellular Double-Stranded DNA. Journal of Virology. 84(2). 822–832. 44 indexed citations
8.
Kobiyama, Kouji, Fumihiko Takeshita, Ken J. Ishii, et al.. (2009). A Signaling Polypeptide Derived from an Innate Immune Adaptor Molecule Can Be Harnessed as a New Class of Vaccine Adjuvant. The Journal of Immunology. 182(3). 1593–1601. 16 indexed citations
9.
Jounai, Nao, Fumihiko Takeshita, Kouji Kobiyama, et al.. (2007). The Atg5–Atg12 conjugate associates with innate antiviral immune responses. Proceedings of the National Academy of Sciences. 104(35). 14050–14055. 486 indexed citations
10.
Kojima, Yoshitsugu, Nao Jounai, Fumihiko Takeshita, et al.. (2006). The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection. Vaccine. 25(3). 438–445. 12 indexed citations
11.
Someya, Kenji, Yasushi Ami, Tadashi Nakasone, et al.. (2006). Induction of Positive Cellular and Humoral Immune Responses by a Prime-Boost Vaccine Encoded with Simian Immunodeficiency Virus gag/pol. The Journal of Immunology. 176(3). 1784–1795. 16 indexed citations
12.
Devito, Claudia, Bartek Zuber, Ulf Schröder, et al.. (2004). Intranasal HIV-1-gp160-DNA/gp41 Peptide Prime-Boost Immunization Regimen in Mice Results in Long-Term HIV-1 Neutralizing Humoral Mucosal and Systemic Immunity. The Journal of Immunology. 173(11). 7078–7089. 54 indexed citations
13.
Okuda, Kenji, Ke-Qin Xin, Susumu Kawamoto, et al.. (2001). Transplacental Genetic Immunization After Intravenous Delivery of Plasmid DNA to Pregnant Mice. The Journal of Immunology. 167(9). 5478–5484. 24 indexed citations
14.
Xin, Ke-Qin, Kaharu Sumino, Eri Hagiwara, et al.. (2000). The Timing of GM-CSF Expression Plasmid Administration Influences the Th1/Th2 Response Induced by an HIV-1-Specific DNA Vaccine. The Journal of Immunology. 164(6). 3102–3111. 116 indexed citations
15.
Asakura, Y., Kenji Hamajima, Jun Fukushima, et al.. (1996). Induction of HIV‐1 Nef‐specific cytotoxic T lymphocytes by Nef‐expressing DNA vaccine. American Journal of Hematology. 53(2). 116–117. 2 indexed citations
16.
Watabe, Setsuko, et al.. (1994). Eliminating MRSA from the Soles of Nurses' Shoes. 9(3). 44–48. 1 indexed citations
17.
Okuda, Kenji. (1986). The Future of Industrial Relations. 28(7). 57–63. 5 indexed citations
18.
Ishii, Norihisa, et al.. (1985). Analysis of Hen Egg White Lysozyme (HEL)-Specific Delayed Type Hypersensitivity Hybridomas. Hybridoma. 4(4). 311–318. 5 indexed citations
19.
Katoh, Kiyoshi, Yoshiaki Ishigatsubo, Jun Chiba, et al.. (1983). Severe Mycoplasmal Pneumonia and Acute Respiratory Failure in a Patient with PSS. Kansenshogaku zasshi. 57(11). 986–990. 1 indexed citations
20.
Takamatsu, Takeichiro, Suteaki Shioya, & Kenji Okuda. (1981). A Comparison of Unstructured Growth Models of Microorganisms. Journal of Fermentation Technology. 59(2). 131–136. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026